Investment Rating - The investment rating for the company is "Buy" [4][10] Core Views - The company reported a revenue of 2.154 billion in H1 2025, representing a year-on-year increase of 10.29%, with a net profit attributable to shareholders of 332 million, up 0.38% year-on-year [1][4] - The growth in revenue is driven by the electronic materials and new energy materials sectors, with H1 gross margin at 38.30% and net margin at 17.39%, showing slight declines compared to the previous year [2][3] - The company is focusing on six major business segments, with strategic investments and acquisitions to enhance its capabilities in biomedical materials and international expansion [3] Summary by Sections Financial Performance - H1 2025 revenue was 21.54 billion, with Q2 revenue at 11.79 billion, showing a quarter-on-quarter increase of 20.97% [1][4] - The gross margin for H1 2025 was 38.30%, with a net margin of 17.39%, reflecting a decrease of 1.59 and 1.63 percentage points year-on-year respectively [2] Business Segments - Revenue from electronic materials, catalytic materials, biomedical materials, architectural ceramics, and new energy materials for H1 2025 was 344 million, 456 million, 438 million, 484 million, and 217 million respectively, with new energy materials showing the highest growth at 26.36% year-on-year [2][3] - The company has made significant advancements in biomedical materials, including the development of high-transparency zirconia powder, and has established a sales network overseas [3] Future Outlook - The company expects net profits attributable to shareholders to reach 774 million, 886 million, and 1.058 billion for the years 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 27.30, 23.85, and 19.97 [3][9]

Core Viewpoint - The company reported a revenue increase of 10.29% year-on-year for the first half of 2025, driven by growth in electronic materials and new energy materials sectors [1][2]. Financial Performance - The company achieved a total revenue of 2.154 billion yuan in H1 2025, with a net profit attributable to shareholders of 332 million yuan, reflecting a year-on-year increase of 0.38% [1]. - In Q2 2025, the company generated revenue of 1.179 billion yuan, showing a quarter-on-quarter increase of 20.97% [1]. - The overall gross margin and net margin for H1 2025 were 38.30% and 17.39%, respectively, with slight declines compared to the previous year [2]. Business Segments - The company’s revenue from various segments in H1 2025 included: electronic materials (344 million yuan, +23.65%), catalytic materials (456 million yuan, +12.34%), biomedical materials (438 million yuan, -0.11%), building ceramics (484 million yuan, +2.59%), and new energy materials (217 million yuan, +26.36%) [2]. - The gross margins for these segments were as follows: electronic materials (32.97%), catalytic materials (41.80%), biomedical materials (52.18%), building ceramics (37.42%), and new energy materials (21.19%) [2]. Strategic Developments - The company is focusing on the collaborative development of six major business segments, with a strategic emphasis on biomedical materials and international expansion [3]. - Recent strategic investments include acquiring Spident in South Korea and Dekema in Germany, enhancing the company’s presence in clinical materials and digital equipment [3]. - The company has developed a high-transparency zirconia powder for aesthetic applications, which has passed validation with multiple clients and is beginning to be supplied in batches [3]. - In the ceramics sector, the company’s subsidiary is a key supplier of ceramic shells for low-orbit satellites [3]. - The company is also advancing in the new energy materials sector, particularly in solid-state battery technologies, with various solid electrolyte products developed [3]. Investment Outlook - The company is expected to see net profits attributable to shareholders of 774 million yuan, 886 million yuan, and 1.058 billion yuan for the years 2025 to 2027, with corresponding price-to-earnings ratios of 27.30, 23.85, and 19.97 [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a steady performance in Q2 2025, with revenue growth driven by the electronic materials and new energy sectors, alongside stable growth in the catalytic materials segment [5][6] - In the first half of 2025, the company achieved revenue of 2.154 billion yuan, a year-on-year increase of 10.29%, and a net profit attributable to shareholders of 332 million yuan, a year-on-year increase of 0.38% [4][5] - The company is expanding its product offerings across multiple sectors, including automotive electronics, AI computing servers, and solid-state battery materials, which are expected to contribute to future growth [6][7] Financial Performance Summary - For Q2 2025, the company reported revenue of 1.179 billion yuan, a year-on-year increase of 4.67% and a quarter-on-quarter increase of 20.97% [4] - The net profit for Q2 2025 was 196 million yuan, a year-on-year decrease of 0.57% but a quarter-on-quarter increase of 44.33% [4] - The company expects net profits for 2025-2027 to be 798 million, 913 million, and 1.16 billion yuan respectively, with year-on-year growth rates of 32.0%, 14.5%, and 26.9% [8] Business Segment Insights - The electronic materials segment is experiencing high growth due to increasing demand for automotive electronics and AI applications, with successful product validation from key clients [5] - The catalytic materials segment has gained traction by supplying ceramic substrates and other products to major international automotive manufacturers [5] - The biomedical materials segment is advancing with the development of dental restoration products, which have begun to see market acceptance [5] - The new energy materials segment is focusing on ultra-thin coatings and has developed various new product models in response to customer needs [5][6]